X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CLSD

Closed

Clearside Biomedical Inc

0.7928
-0.0072 (-0.90%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.8
Day's Range: 0.79 - 0.8194
Send
When Written:
 
1.04
Clearside Biomedical Inc is a biopharmaceutical company that is focused on developing and commercializing innovative therapies to treat blinding diseases of the eye. The company's proprietary SCS Microinjector is a highly precise and targeted drug delivery system that enables the administration of therapeutics to the suprachoroidal space (SCS) of the eye.

Clearside's lead product candidate, Xipere (triamcinolone acetonide ophthalmic suspension), is a corticosteroid that is being developed for the treatment of macular edema associated with uveitis, a leading cause of blindness. The company is also developing CLS-AX, a combination of Xipere and axitinib, a tyrosine kinase inhibitor, for the treatment of wet age-related macular degeneration.

Clearside was founded in 2011 and is headquartered in Alpharetta, Georgia. The company went public in 2016 and is traded on the NASDAQ under the ticker symbol CLSD.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X